Tokyo, June 25 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062038) titled 'The Effect of Ingestion of Ginkgo Biloba-derived Flavonoid Glycosides and Terpene Lactones on Cognitive Function: A Systematic Review' on June 25.
Study Type:
Others,meta-analysis etc
Primary Sponsor:
Institute - Yakujihou Marketing Jimusho Co., Ltd.
Condition:
Condition - Healthy adults aged 40 years or older.
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To evaluate the effects of Ginkgo biloba-derived flavonoid glycosides and terpene lactones intake on cognitive function.
Basic objectives2 - Efficacy
Eligibility:
Age-lower limit - 40
years-old
<=
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - Healthy adults aged 40 and older with no diagnosed diseases.
Key exclusion criteria - Individuals with diseases, pregnant women (including those planning to become pregnant), and lactating women.
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2026 Year 06 Month 19 Day
Anticipated trial start date - 2026 Year 06 Month 26 Day
Last follow-up date - 2026 Year 08 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000070920
Disclaimer: Curated by HT Syndication.
